XML 28 R16.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Scienture Inc. 2020 Stock Option and Grant Plan | 6 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2024 | Dec. 31, 2023
Scienture Inc [Member] |  |
Scienture Inc. 2020 Stock Option and Grant Plan | Note 10 Scienture Inc. 2020 Stock Option and Grant Plan The Stock Option and Grant Plan allows for the issuance of incentive stock options (“ISOs”), non-statutory stock options (“NSOs”). ISOs may be granted only to the Company’s employees (including officers and directors who are also considered employees) and ex-employees. NSOs may be granted to the Company’s employees and service providers such as advisors etc. Options under the Stock Option and Grant Plan have a contractual term of not more than 10 years. A summary of the Company’s stock option activity under the Plans is as follows: Summary of Stock Option Activity
|  | Outstanding Options |  |  | Weighted- Average Exercise Price |  |  | Weighted- Average Remaining Term (Years) |
Balance as of December 31, 2023 |  |  | 655,000 |  |  | $ | 0.90 |  |  |  | 7.56 |
Granted |  |  | 142,199 |  |  |  | 1.13 |  |  |  |  |
Exercised |  |  | - |  |  |  | - |  |  |  |  |
Cancelled and forfeited |  |  | - |  |  |  | - |  |  |  |  |
Balance as of June 20, 2024 |  |  | 797,199 |  |  | $ | 0.94 |  |  |  | 6.21 |
Vested and exercisable as of June 30, 2024 |  |  | 499,089 |  |  | $ | 0.84 |  |  |  | 5.62 |
The weighted-average grant date fair value of options granted during the six months ended June 30, 2024 was $0.76 per share. The Company recorded stock-based compensation expense in the Statement of Operations and Comprehensive Loss for the periods presented as follows: Schedule of Stock-based Compensation Expense
|  | 2024 |  |  | 2023 |
|  | June 30, |
|  | 2024 |  |  | 2023 |
General and Administrative Expenses |  | $ | 44,837 |  |  | $ | 39,724 |
Total stock-based compensation expense |  | $ | 44,837 |  |  | $ | 39,724 |
Stock Option Valuation Assumptions The fair value of each employee option grant was estimated on the date of grant using the Black-Scholes option pricing model and the following assumptions for the periods indicated: Schedule of Stock Option Valuation Assumptions
|  | June 30, |
|  | 2024 |  |  | 2023 |
Expected volatility |  |  | 72 | % |  |  | 65% - 75 | %
Risk-free interest rate |  |  | 4.1% - 4.4 | % |  |  | 0.5% - 3.5 | %
Expected term |  |  | 5.7 - 6.1 years |  |  |  | 5.9 - 6.0 years |
Expected dividend |  |  | 0 | % |  |  | 0 | %
| Note 10 Scienture Inc. 2020 Stock Option and Grant Plan The Stock Option and Grant Plan allows for the issuance of incentive stock options (“ISOs”), non-statutory stock options (“NSOs”). ISOs may be granted only to the Company’s employees (including officers and directors who are also considered employees) and ex-employees. NSOs may be granted to the Company’s employees and service providers such as advisors etc. Options under the Stock Option and Grant Plan have a contractual term of not more than 10 years. A summary of the Company’s stock option activity under the Plans is as follows: Summary of Stock Option Activity
|  | Outstanding Options |  |  | Weighted- Average Exercise Price |  |  | Weighted- Average Remaining Term (Years) |
Balance as of December 31, 2022 |  |  | 560,000 |  |  | $ | 0.83 |  |  |  | 7.95 |
Granted |  |  | 185,000 |  |  |  | 1.13 |  |  |  |  |
Exercised |  |  | - |  |  |  | - |  |  |  |  |
Cancelled and forfeited |  |  | (90,000 | ) |  |  | - |  |  |  |  |
Balance as of December 31, 2023 |  |  | 655,000 |  |  | $ | 0.90 |  |  |  | 7.56 |
Vested and exercisable as of December 31, 2023 |  |  | 410,065 |  |  | $ | 0.84 |  |  |  | 6.84 |
The weighted-average grant date fair value of options granted during the years ended December 31, 2023 and 2022 are $ 0.55 and $ 0.52 per share respectively. The Company recorded stock-based compensation expense in the Statement of Operations and Comprehensive Loss for the periods presented as follows: Schedule of Stock-based Compensation Expense
|  | 2023 |  |  | 2022 |
|  | December 31, |
|  | 2023 |  |  | 2022 |
General and Administrative Expenses |  | $ | 79,449 |  |  | $ | 68,087 |
Total stock-based compensation expense |  | $ | 79,449 |  |  | $ | 68,087 |
Stock Option Valuation Assumptions The fair value of each employee option grant was estimated on the date of grant using the Black-Scholes option pricing model and the following assumptions for the periods indicated: Schedule of Stock Option Valuation Assumptions
|  | December 31, |
|  | 2023 |  |  | 2022 |
Expected volatility |  |  | 65% - 75 | % |  |  | 65% - 75 | %
Risk-free interest rate |  |  | 0.5% - 3.5 | % |  |  | 0.5% - 2.8 | %
Expected term |  |  | 5.9 - 6.0 years |  |  |  | 5.9 - 6.0 years |
Expected dividend |  |  | 0 | % |  |  | 0 | %

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=SCNX_ScientureIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |